𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms

✍ Scribed by Michael Ussher; Paul Aveyard; Fiona Reid; Robert West; Phil Evans; Angela Clow; Frank Hucklebridge; Julie Fuller; Judith Ibison; Andrew Steptoe


Publisher
Springer
Year
2011
Tongue
English
Weight
171 KB
Volume
216
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treating alcohol withdrawal with oral ba
✍ Jeffrey E. Lyon; Raza A. Khan; Charles E. Gessert; Pamela M. Larson; Colleen M. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 307 KB

## Abstract ## BACKGROUND: Abrupt cessation of alcohol intake causes habituated drinkers to experience symptoms of alcohol withdrawal syndrome (AWS). ## OBJECTIVE: To determine the effect of the gamma‐aminobutyric acid (GABA)‐B agonist baclofen on the course of acute symptomatic AWS. ## DESIGN:

Fluoxetine vs placebo for depressive sym
✍ M. Ruddell; A. Spencer; K. Hill; A. House πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

## Abstract ## Background Growth in antidepressant prescribing is a well‐recognised phenomenon in developed countries. In stroke care, the evidence of effectiveness from systematic reviews is surprisingly weak. We therefore decided to undertake a randomised controlled trial comparing fluoxetine to

A randomised, controlled, crossover tria
✍ K. E. Wilson; R. R. Welbury; N. M. Girdler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 239 KB

**Summary** A randomised, controlled, crossover trial was designed to assess the safety and effectiveness of oral midazolam sedation for orthodontic extractions. Forty‐six ASA physical status I children aged 10–16 years were recruited. Each child required two treatment sessions. Sedation with either